Is paradoxical pharmacology a strategy worth pursuing?

被引:46
作者
Bond, RA [1 ]
机构
[1] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0165-6147(00)01711-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The first rule of medicine is, 'do no harm', Perhaps accepting this precept has produced a logic for disease treatment where our primary purpose is limited to only assisting or helping to correct a malfunctioning system. Can we use drugs that, according to traditional views, would be considered to increase stress on the system in the short term, to actually treat and cure disease in the long term? Is it possible to exacerbate disease for a longer-term gain? Although there are several examples of where this strategy has appeared to work, a systematic testing of the hypothesis has not occurred and, for the majority of diseases, this hypothesis has never been tested.
引用
收藏
页码:273 / 276
页数:4
相关论文
共 22 条
[1]   Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia [J].
Arnold, SE ;
Trojanowski, JQ ;
Gur, RE ;
Blackwell, P ;
Han, LY ;
Choi, C .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (03) :225-232
[2]   ELDERLY PATIENTS WITH SCHIZOPHRENIA EXHIBIT INFREQUENT NEURODEGENERATIVE LESIONS [J].
ARNOLD, SE ;
FRANZ, BR ;
TROJANOWSKI, JQ .
NEUROBIOLOGY OF AGING, 1994, 15 (03) :299-303
[3]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[4]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[5]   β-blocker therapy for heart failure -: The evidence is in, now the work begins [J].
Califf, RM ;
O'Connor, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1335-1337
[6]   ADVERSE-EFFECTS OF ALPHA-U-ADRENERGIC BLOCKING-DRUGS [J].
CARRUTHERS, SG .
DRUG SAFETY, 1994, 11 (01) :12-20
[7]   Beta-blockers after myocardial infarction: Do benefits ever outweigh risks in asthma? [J].
Chafin, CC ;
Soberman, JE ;
Demirkan, K ;
Self, T .
CARDIOLOGY, 1999, 92 (02) :99-105
[8]   Rational use of inotropic therapy in heart failure. [J].
Felker G.M. ;
O'Connor C.M. .
Current Cardiology Reports, 2001, 3 (2) :108-113
[9]   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302
[10]  
Hjalmarson Å, 1999, LANCET, V353, P2001